Cite
Tamayo-Velasco Á, Martínez-Paz P, Peñarrubia-Ponce MJ, et al. HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. J Clin Med. 2021;10(9)doi: 10.3390/jcm10092017.
Tamayo-Velasco, �. �., Martínez-Paz, P., Peñarrubia-Ponce, M. J., de la Fuente, I., Pérez-González, S., Fernández, I., Dueñas, C., Gómez-Sánchez, E., Lorenzo-López, M., Gómez-Pesquera, E., Heredia-Rodríguez, M., Carnicero-Frutos, I., Muñoz-Moreno, M. F., Bernardo, D., Álvarez, F. J., Tamayo, E., & Gonzalo-Benito, H. (2021). HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. Journal of clinical medicine, 10(9), . https://doi.org/10.3390/jcm10092017
Tamayo-Velasco, Álvaro, et al. "HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients." Journal of clinical medicine vol. 10,9 (2021). doi: https://doi.org/10.3390/jcm10092017
Tamayo-Velasco Á, Martínez-Paz P, Peñarrubia-Ponce MJ, de la Fuente I, Pérez-González S, Fernández I, Dueñas C, Gómez-Sánchez E, Lorenzo-López M, Gómez-Pesquera E, Heredia-Rodríguez M, Carnicero-Frutos I, Muñoz-Moreno MF, Bernardo D, Álvarez FJ, Tamayo E, Gonzalo-Benito H. HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. J Clin Med. 2021 May 08;10(9). doi: 10.3390/jcm10092017. PMID: 34066892; PMCID: PMC8125923.
Copy
Download .nbib